精密精神医学市場レポート：製品タイプ、サンプル、バイオマーカータイプ、技術、用途、エンドユーザー、地域別、2025年～2033年

精密精神医学市場の世界市場規模は、2024年に12億2,400万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに42億7,030万米ドルに達し、2025年から2033年の間に14.9%の成長率（CAGR）を示すと予測しています。大衆の間で精神疾患の有病率が上昇していること、個別化された治療計画や介入に対するニーズが高まっていること、遺伝子検査やデータ分析の登場が市場を牽引する主な要因となっています。

精密精神医学は、メンタルヘルスケアに広く採用されている革新的な医療アプローチを指します。数多くの先端技術と個別化医療を活用し、精神疾患に苦しむ人々により的を絞った効果的な治療を提供します。うつ病、不安障害、双極性障害、統合失調症などの精神疾患は、遺伝的、環境的、生活習慣的要因の組み合わせに影響される複雑で多面的な疾患であることを認識しています。遺伝的構成、神経生物学的マーカー、個人的状況など、個人のユニークな特徴に基づいて複数の介入を調整することを目的としています。これにより、臨床医は精神疾患の根底にあるメカニズムについてより深い洞察を得ることができ、それに応じて個別化された治療計画を立てることができます。これに加えて、特定の精神疾患のかかりやすさに寄与したり、特定の薬物療法への反応に影響したりする可能性のある特定の遺伝的変異を特定することもできます。このような情報により、より適切で的を絞った治療法を選択することが可能となり、副作用の可能性を最小限に抑えつつ、良好な結果をもたらす可能性を高めることができます。

精密精神医学の市場傾向：

世界市場の主な原動力は、大衆における精神疾患の有病率の上昇です。個別化された治療計画や介入に対するニーズの高まりと相まって、個人の間で精密精神医学の採用が大幅に増加しています。精密精神医学は、様々な医療分野における個別化医療に向けた幅広い動向と一致しているからです。これは、各個人がユニークであり、遺伝的、神経生物学的、環境的要因に基づいたオーダーメイドの治療が必要であることを認識するものです。この個別化アプローチは、より効果的な治療と転帰の改善が期待できることから患者の共感を呼び、大衆の間で広く注目されるようになっています。さらに、遺伝子検査、ニューロイメージング、データ分析などの継続的な技術進歩は、精密精神医学の開発と実施に大きく貢献し、市場にさらに好影響を与えています。これとは別に、精密精神医学への関心の高まりは、研究活動や資金援助の増加を伴っています。学術機関、研究機関、製薬会社は、精神疾患の生物学的メカニズムをよりよく理解し、標的治療を開発するための研究に投資しており、それが市場に刺激を与えています。急速な都市化、個人の意識の高まり、ヘルスケアインフラの継続的な開拓など、その他の要因も市場にプラスの影響を与えています。

本レポートで扱う主な質問

• 世界の精密精神医学市場はこれまでどのように推移してきたか？
• 世界の精密精神医学市場における促進要因、抑制要因、機会は何か？
• 各駆動要因、抑制要因、機会が世界の精密精神医学市場に与える影響は？
• 主要な地域市場とは？
• 最も魅力的な精密精神医学市場はどの国か？
• 製品タイプ別の市場内訳は？
• 精密精神医学市場で最も魅力的な製品タイプは？
• サンプル別の市場内訳は？
• 精密精神医学市場で最も魅力的なサンプルは？
• バイオマーカータイプに基づく市場内訳は？
• 精密精神医学市場で最も魅力的なバイオマーカータイプは？
• 技術に基づく市場内訳は？
• 精密精神医学市場で最も魅力的な技術はどれか？
• 用途別の市場内訳は？
• 精密精神医学市場で最も魅力的な用途は？
• エンドユーザー別の市場内訳は？
• 精密精神医学市場で最も魅力的なエンドユーザーは？
• 世界の精密精神医学市場の競合構造は？
• 世界の精密精神医学市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の精密精神医学市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• 製品
  • 市場動向
  • 市場予測
• サービス
  • 市場動向
  • 市場予測

第7章 市場内訳：サンプル

• 血液ベース
  • 市場動向
  • 市場予測
• 非血液ベース
  • 市場動向
  • 主要セグメント
    • 唾液
    • 尿
    • 脳脊髄液（CSF）
    • その他
  • 市場予測

第8章 市場内訳：バイオマーカータイプ別

• 遺伝子バイオマーカー
  • 市場動向
  • 市場予測
• タンパク質バイオマーカー
  • 市場動向
  • 市場予測

第9章 市場内訳：技術別

• シーケンシング
  • 市場動向
  • 主要セグメント
    • 次世代シーケンシング（NGS）
    • サンガーシーケンス
  • 市場予測
• ポリメラーゼ連鎖反応（PCR）
  • 市場動向
  • 主要セグメント
    • リアルタイムポリメラーゼ連鎖反応（RT-PCR）
    • デジタルポリメラーゼ連鎖反応（dPCR）
  • 市場予測
• マイクロアレイ
  • 市場動向
  • 市場予測
• 免疫測定
  • 市場動向
  • 市場予測
• 液体クロマトグラフィー質量分析法（LC-MS）
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：用途別

• アルツハイマー病
  • 市場動向
  • 市場予測
• パーキンソン病
  • 市場動向
  • 市場予測
• 自閉症
  • 市場動向
  • 市場予測
• うつ
  • 市場動向
  • 市場予測
• 双極性障害
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第11章 市場内訳：エンドユーザー別

• 病院および診断研究所
  • 市場動向
  • 市場予測
• 学術調査機関
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第12章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第13章 促進要因・抑制要因・機会

• 概要
• 促進要因
• 抑制要因
• 機会

第14章 バリューチェーン分析

第15章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第16章 価格分析

第17章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Altimate Healthcare
  • Alto Nanoscience
  • ATAI Life Sciences N.V.
  • Fulgent Genetics Inc.
  • Invitae Corporation
  • Myriad Genetics Inc.
  • Precision Psychiatric Services Inc.
  • Tempus Labs Inc.

List of Figures

• Figure 1: Global: Precision Psychiatry Market: Major Drivers and Challenges
• Figure 2: Global: Precision Psychiatry Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Precision Psychiatry Market: Breakup by Product Type (in %), 2024
• Figure 5: Global: Precision Psychiatry Market: Breakup by Sample (in %), 2024
• Figure 6: Global: Precision Psychiatry Market: Breakup by Biomarker Type (in %), 2024
• Figure 7: Global: Precision Psychiatry Market: Breakup by Technology (in %), 2024
• Figure 8: Global: Precision Psychiatry Market: Breakup by Application (in %), 2024
• Figure 9: Global: Precision Psychiatry Market: Breakup by End User (in %), 2024
• Figure 10: Global: Precision Psychiatry Market: Breakup by Region (in %), 2024
• Figure 11: Global: Precision Psychiatry (Products) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Precision Psychiatry (Products) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Precision Psychiatry (Services) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Precision Psychiatry (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Precision Psychiatry (Blood-Based) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Precision Psychiatry (Blood-Based) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Precision Psychiatry (Non-Blood-Based) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Precision Psychiatry (Non-Blood-Based) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Precision Psychiatry (Genetic Biomarker) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Precision Psychiatry (Genetic Biomarker) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Precision Psychiatry (Protein Biomarker) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Precision Psychiatry (Protein Biomarker) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Precision Psychiatry (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Precision Psychiatry (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Precision Psychiatry (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Precision Psychiatry (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Precision Psychiatry (Immunoassay) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Precision Psychiatry (Immunoassay) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Precision Psychiatry (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Precision Psychiatry (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Precision Psychiatry (Alzheimer's Disease) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Precision Psychiatry (Alzheimer's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Global: Precision Psychiatry (Parkinson's Disease) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Global: Precision Psychiatry (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Global: Precision Psychiatry (Autism) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Global: Precision Psychiatry (Autism) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Global: Precision Psychiatry (Depression) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Global: Precision Psychiatry (Depression) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Global: Precision Psychiatry (Bipolar Disease) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Global: Precision Psychiatry (Bipolar Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Global: Precision Psychiatry (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Global: Precision Psychiatry (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Global: Precision Psychiatry (Academic and Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Global: Precision Psychiatry (Academic and Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Global: Precision Psychiatry (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Global: Precision Psychiatry (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: North America: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: North America: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: United States: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: United States: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Canada: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Canada: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Asia-Pacific: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Asia-Pacific: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: China: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: China: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Japan: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Japan: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: India: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: India: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: South Korea: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: South Korea: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Australia: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Australia: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Indonesia: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Indonesia: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Others: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Others: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Europe: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Europe: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Germany: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Germany: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: France: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 80: France: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 81: United Kingdom: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 82: United Kingdom: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 83: Italy: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 84: Italy: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 85: Spain: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 86: Spain: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 87: Russia: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 88: Russia: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 89: Others: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 90: Others: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 91: Latin America: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 92: Latin America: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 93: Brazil: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 94: Brazil: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 95: Mexico: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 96: Mexico: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 97: Others: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 98: Others: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 99: Middle East and Africa: Precision Psychiatry Market: Sales Value (in Million USD), 2019 & 2024
• Figure 100: Middle East and Africa: Precision Psychiatry Market: Breakup by Country (in %), 2024
• Figure 101: Middle East and Africa: Precision Psychiatry Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 102: Global: Precision Psychiatry Industry: Drivers, Restraints, and Opportunities
• Figure 103: Global: Precision Psychiatry Industry: Value Chain Analysis
• Figure 104: Global: Precision Psychiatry Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Precision Psychiatry Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Precision Psychiatry Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
• Table 3: Global: Precision Psychiatry Market Forecast: Breakup by Sample (in Million USD), 2025-2033
• Table 4: Global: Precision Psychiatry Market Forecast: Breakup by Biomarker Type (in Million USD), 2025-2033
• Table 5: Global: Precision Psychiatry Market Forecast: Breakup by Technology (in Million USD), 2025-2033
• Table 6: Global: Precision Psychiatry Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 7: Global: Precision Psychiatry Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 8: Global: Precision Psychiatry Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 9: Global: Precision Psychiatry Market: Competitive Structure
• Table 10: Global: Precision Psychiatry Market: Key Players

The global precision psychiatry market size reached USD 1,224 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,270.3 Million by 2033, exhibiting a growth rate (CAGR) of 14.9% during 2025-2033. The rising prevalence of mental health disorders among the masses, the growing need for personalized treatment plans and interventions and the advent of genetic testing, and data analytics represent some of the key factors driving the market.

Precision psychiatry refers to an innovative medical approach that is widely adopted for mental health care. It leverages numerous advanced technologies and personalized medicine to provide more targeted and effective treatments for individuals suffering from psychiatric disorders. It recognizes that mental illnesses, such as depression, anxiety, bipolar disorder, and schizophrenia, are complex and multifaceted conditions influenced by a combination of genetic, environmental, and lifestyle factors. It aims to tailor multiple interventions based on an individual's unique characteristics, including their genetic makeup, neurobiological markers, and personal circumstances. It allows clinicians to gain deeper insights into the underlying mechanisms of psychiatric disorders and develop personalized treatment plans accordingly. Besides this, it also identifies specific genetic variations that may contribute to the susceptibility to certain mental health conditions or influence the response to particular medications. This information allows for the selection of more appropriate and targeted treatment options, increasing the likelihood of positive outcomes while minimizing the potential for adverse effects.

Precision Psychiatry Market Trends:

The global market is majorly driven by the rising prevalence of mental health disorders among the masses. Coupled with the growing need for personalized treatment plans and interventions, there has been a considerable increase in the adoption of precision psychiatry among individuals. Since precision psychiatry aligns with the broader trend toward personalized medicine across various medical fields. It recognizes that each individual is unique and requires tailored treatments based on their genetic, neurobiological, and environmental factors. This personalized approach resonates with patients, as it offers the prospect of more effective treatments and improved outcomes, which is gaining widespread prominence among the masses. Moreover, continual technological advancements, such as the advent of genetic testing, neuroimaging, and data analytics have significantly contributed to the development and implementation of precision psychiatry, further impacting the market favorably. Apart from this, the growing interest in precision psychiatry is accompanied by rising research activities and funding support. Academic institutions, research organizations, and pharmaceutical companies are investing in research to better understand the biological mechanisms of psychiatric disorders and develop targeted treatments, hence providing an impetus to the market. Other factors, including rapid urbanization, growing awareness among individuals and continual developments in the healthcare infrastructure, are also positively influencing the market.

Key Market Segmentation:

Product Type Insights:

• Products
• Services

Sample Insights:

• Blood-Based
• Non-Blood-Based
• Saliva
• Urine
• Cerebral Spinal Fluid (CSF)
• Others

Biomarker Type Insights:

• Genetic Biomarker
• Protein Biomarker

Technology Insights:

• Sequencing
• Next-Generation Sequencing (NGS)
• Sanger Sequencing
• Polymerase Chain Reaction (PCR)
• Real-Time Polymerase Chain Reaction (RT-PCR)
• Digital Polymerase Chain Reaction (dPCR)
• Microarray
• Immunoassay
• Liquid Chromatography-Mass Spectrometry (LC-MS)
• Others

Application Insights:

• Alzheimer's Disease
• Parkinson's Disease
• Autism
• Depression
• Bipolar Disease
• Others

End User Insights:

• Hospitals and Diagnostic Laboratories
• Academic and Research Institutions
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for precision psychiatry. Some of the factors driving the North America precision psychiatry market included the growing awareness among the masses, the emerging healthcare industry, the shifting lifestyle preferences of the masses, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global precision psychiatry market. Detailed profiles of all major companies have been provided. Some of the companies covered include Altimate Healthcare, Alto Nanoscience, ATAI Life Sciences N.V., Fulgent Genetics Inc, Invitae Corporation, Myriad Genetics Inc., Precision Psychiatric Services Inc., Tempus Labs Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global precision psychiatry market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global precision psychiatry market?
• What is the impact of each driver, restraint, and opportunity on the global precision psychiatry market?
• What are the key regional markets?
• Which countries represent the most attractive precision psychiatry market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the precision psychiatry market?
• What is the breakup of the market based on the sample?
• Which is the most attractive sample in the precision psychiatry market?
• What is the breakup of the market based on the biomarker type?
• Which is the most attractive biomarker type in the precision psychiatry market?
• What is the breakup of the market based on technology?
• Which is the most attractive technology in the precision psychiatry market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the precision psychiatry market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the precision psychiatry market?
• What is the competitive structure of the global precision psychiatry market?
• Who are the key players/companies in the global precision psychiatry market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Precision Psychiatry Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Sample

• 7.1 Blood-Based
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Non-Blood-Based
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Saliva
    • 7.2.2.2 Urine
    • 7.2.2.3 Cerebral Spinal Fluid (CSF)
    • 7.2.2.4 Others
  • 7.2.3 Market Forecast

8 Market Breakup by Biomarker Type

• 8.1 Genetic Biomarker
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Protein Biomarker
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Technology

• 9.1 Sequencing
  • 9.1.1 Market Trends
  • 9.2.2 Key Segments
    • 9.2.2.1 Next-Generation Sequencing (NGS)
    • 9.2.2.2 Sanger Sequencing
  • 9.1.3 Market Forecast
• 9.2 Polymerase Chain Reaction (PCR)
  • 9.2.1 Market Trends
  • 9.2.2 Key Segments
    • 9.2.2.1 Real-Time Polymerase Chain Reaction (RT-PCR)
    • 9.2.2.2 Digital Polymerase Chain Reaction (dPCR)
  • 9.2.3 Market Forecast
• 9.3 Microarray
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Immunoassay
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Liquid Chromatography-Mass Spectrometry (LC-MS)
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast
• 9.6 Others
  • 9.6.1 Market Trends
  • 9.6.2 Market Forecast

10 Market Breakup by Application

• 10.1 Alzheimer's Disease
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Parkinson's Disease
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Autism
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Depression
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Bipolar Disease
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast
• 10.6 Others
  • 10.6.1 Market Trends
  • 10.6.2 Market Forecast

11 Market Breakup by End User

• 11.1 Hospitals and Diagnostic Laboratories
  • 11.1.1 Market Trends
  • 11.1.2 Market Forecast
• 11.2 Academic and Research Institutions
  • 11.2.1 Market Trends
  • 11.2.2 Market Forecast
• 11.3 Others
  • 11.3.1 Market Trends
  • 11.3.2 Market Forecast

12 Market Breakup by Region

• 12.1 North America
  • 12.1.1 United States
    • 12.1.1.1 Market Trends
    • 12.1.1.2 Market Forecast
  • 12.1.2 Canada
    • 12.1.2.1 Market Trends
    • 12.1.2.2 Market Forecast
• 12.2 Asia-Pacific
  • 12.2.1 China
    • 12.2.1.1 Market Trends
    • 12.2.1.2 Market Forecast
  • 12.2.2 Japan
    • 12.2.2.1 Market Trends
    • 12.2.2.2 Market Forecast
  • 12.2.3 India
    • 12.2.3.1 Market Trends
    • 12.2.3.2 Market Forecast
  • 12.2.4 South Korea
    • 12.2.4.1 Market Trends
    • 12.2.4.2 Market Forecast
  • 12.2.5 Australia
    • 12.2.5.1 Market Trends
    • 12.2.5.2 Market Forecast
  • 12.2.6 Indonesia
    • 12.2.6.1 Market Trends
    • 12.2.6.2 Market Forecast
  • 12.2.7 Others
    • 12.2.7.1 Market Trends
    • 12.2.7.2 Market Forecast
• 12.3 Europe
  • 12.3.1 Germany
    • 12.3.1.1 Market Trends
    • 12.3.1.2 Market Forecast
  • 12.3.2 France
    • 12.3.2.1 Market Trends
    • 12.3.2.2 Market Forecast
  • 12.3.3 United Kingdom
    • 12.3.3.1 Market Trends
    • 12.3.3.2 Market Forecast
  • 12.3.4 Italy
    • 12.3.4.1 Market Trends
    • 12.3.4.2 Market Forecast
  • 12.3.5 Spain
    • 12.3.5.1 Market Trends
    • 12.3.5.2 Market Forecast
  • 12.3.6 Russia
    • 12.3.6.1 Market Trends
    • 12.3.6.2 Market Forecast
  • 12.3.7 Others
    • 12.3.7.1 Market Trends
    • 12.3.7.2 Market Forecast
• 12.4 Latin America
  • 12.4.1 Brazil
    • 12.4.1.1 Market Trends
    • 12.4.1.2 Market Forecast
  • 12.4.2 Mexico
    • 12.4.2.1 Market Trends
    • 12.4.2.2 Market Forecast
  • 12.4.3 Others
    • 12.4.3.1 Market Trends
    • 12.4.3.2 Market Forecast
• 12.5 Middle East and Africa
  • 12.5.1 Market Trends
  • 12.5.2 Market Breakup by Country
  • 12.5.3 Market Forecast

13 Drivers, Restraints, and Opportunities

• 13.1 Overview
• 13.2 Drivers
• 13.3 Restraints
• 13.4 Opportunities

14 Value Chain Analysis

15 Porters Five Forces Analysis

• 15.1 Overview
• 15.2 Bargaining Power of Buyers
• 15.3 Bargaining Power of Suppliers
• 15.4 Degree of Competition
• 15.5 Threat of New Entrants
• 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

• 17.1 Market Structure
• 17.2 Key Players
• 17.3 Profiles of Key Players
  • 17.3.1 Altimate Healthcare
    • 17.3.1.1 Company Overview
    • 17.3.1.2 Product Portfolio
  • 17.3.2 Alto Nanoscience
    • 17.3.2.1 Company Overview
    • 17.3.2.2 Product Portfolio
  • 17.3.3 ATAI Life Sciences N.V.
    • 17.3.3.1 Company Overview
    • 17.3.3.2 Product Portfolio
  • 17.3.4 Fulgent Genetics Inc.
    • 17.3.4.1 Company Overview
    • 17.3.4.2 Product Portfolio
  • 17.3.5 Invitae Corporation
    • 17.3.5.1 Company Overview
    • 17.3.5.2 Product Portfolio
  • 17.3.6 Myriad Genetics Inc.
    • 17.3.6.1 Company Overview
    • 17.3.6.2 Product Portfolio
  • 17.3.7 Precision Psychiatric Services Inc.
    • 17.3.7.1 Company Overview
    • 17.3.7.2 Product Portfolio
  • 17.3.8 Tempus Labs Inc.
    • 17.3.8.1 Company Overview
    • 17.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.